14 results · 23ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

GEN-PROBE APTIMA COMBO 2 ASSAY

FDA 510(k)
FDA Class 2 ·Microbiology

Premier Elevator

FDA UDI
PREMIER DENTAL PRODUCTS COMPANY·00348783004212·ELEVATOR POTTS 2

SCANLAN® Needle Holders

FDA UDI
SCANLAN INTERNATIONAL INC·00846159022780·Puskas™ Jacobson Micro Needle Holder

QUASAR

FDA UDI
Modus Medical Devices Inc·G34350033950·RESP-Cedar Ion Chamber Holder(drilled)

ORTHO SUMMIT SAMPLE HANDLING SYSTEM

FDA Adverse Event
Malfunction ·HAMILTON BONADUZ AG·Product code JTC·August 18, 2000

EINSTEIN PROCESSING AND REVIEW WORKSTATION

FDA 510(k)
FDA Class 2 ·Radiology

MODEL 30 CLASSIC PNEUMATONOMETER

FDA 510(k)
FDA Class 2 ·Ophthalmic

ZPower Rechargeable System for Hearing Aids

FDA UDI
ZPOWER, LLC·00811204030218·Charger for ZPower Rechargeable System for Hear...

DISTRACTOR TIP FOR MATRIX

FDA Adverse Event
Malfunction ·SYNTHES MONUMENT·Product code LXH·February 28, 2013

ASKU

FDA Adverse Event
Malfunction ·MEDTRONIC MILACA INC.·Product code DTE·March 1, 2011

VENATECH LP VENA CAVA FILTER

FDA Adverse Event
Injury ·B BRAUN MEDICAL SAS·Product code DTK·February 22, 2008

smiths medical PORTEX Tracheal Tube Exchange Guide, 10Ch x 70cm, REF 14-504-76

FDA Enforcement
Class II ·Ongoing·Smiths Medical ASD, Inc.·December 4, 2024

Boston Scientific/Cameron Health SQ-RX Model 1010 subcutaneous pulse generators. The S-ICD System is intended to provide therapy for the treatment of life-threatening ventricular tachyarrhythmias.

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·March 27, 2013

CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024